Animal Care Post Approval Monitoring
According to the Guide for the Care and Use of Laboratory Animals, the Institutional Animal Care and Use Committee (IACUC) is responsible for overseeing and evaluating the university’s animal program, procedures and facilities to ensure they are consistent with the recommendations in the guide, the regulations of the Animal Welfare Act, and the Public Health Service Policy on Humane Care and Use of Laboratory Animals. A continuing program to audit approved animal use protocols is an essential component of a comprehensive Animal Care and Use Program.
Expand all | Collapse all
What is Post-Approval Monitoring (PAM)?
Post-approval monitoring is an examination of the research facility and study documents (approved protocols) to ensure that animal subjects are protected, and the investigator is in compliance with applicable university and federal regulations. Conducting post-approval monitoring will help to ensure that appropriate applications and supporting documents are implemented as approved, and any changes or adverse events/outcomes are reported.
What are the goals of the PAM process?
The primary goals of the PAM program are to ensure animal well-being and to maintain regulatory compliance. Associated with this, the process will facilitate the science by serving as a resource to the research community. The PAM process is positioned to convey IACUC policies on matters of animal care and to identify education and training needs of laboratory staff. Ultimately, the PAM process will confirm that the manner in which the IACUC understood and approved an animal protocol is consistent with the way its procedures are being performed.
What are some of the benefits that a PI may gain from the PAM process?
When scientific research involves animals, reliable results depend on proper and consistent animal care. Animal protocols are approved with the principles of humane care and use of animals in mind. These principles are transmitted by regulatory bodies, and compliance is mandatory. Some of the possible benefits that may be gained from a review include but are not limited to:
- Increased understanding of the regulations that guide all of our research projects.
- Increased communication concerning updates to federal and university regulations.
- Access to resources and individuals to clarify the federal and university regulations.
How does the PAM process protect my research?
The PAM process wants to correct protocol issues internally so that regulatory agency inspectors are less likely to find problems. Should PAM find that animals are harmed due to major deviation from the protocol, the IACUC may suspend that lab’s animal work until the practice is corrected. This is one of the responsibilities of an IACUC, as mandated by federal regulations. If a regulatory agency identifies the non-compliance situation, it may revoke research privileges for the entire campus. It is better for the IACUC to suspend research in a single noncompliant lab than for a regulatory body to stop research in the entire institution due to the disregard for compliance in a single lab.
What are Marquette's obligations to regulatory bodies?
In response to increasing oversight and consequences imposed by regulators, PAM has become the industry's standard practice. The IACUC is currently responsible for conducting a continuing review of approved protocols in accordance with Public Health Service Policy (IV.C.5.) and Animal Welfare Regulations (Sec2.31(d)). Marquette‘s institutional official must sign an Animal Welfare Assurance Statement for OLAW, promising that Marquette will conduct animal research in accordance with federal policy, the Guide for the Care and Use of Laboratory Animals, and other applicable regulations.
Why do we need AAALAC certification?
Many private funding sources strongly recommend that grantees receiving support have animal programs with AAALAC accreditation. The NIH, NSF, NASA, DOD and VA consider AAALAC accreditation a commitment to excellence. More than 750 institutions in 30 countries have earned AAALAC accreditation, thus it is an international symbol of quality. AAALAC accreditation requires that we demonstrate not only that we meet the minimum standards required by law, but also that we take extra steps to achieve excellence in animal care and use and thus promote scientific validity.
How are the protocols selected?
Protocols are randomly selected from a pool of all approved IACUC protocols. If a protocol has been selected, it does not necessarily mean the PI is doing something wrong. Protocols can be selected for cause from a complainant and/or unexpected outcomes reporting.
How long will the assessment take?
If your documents are complete and organized, the review will take about one hour. If an investigator is not prepared, the review may take several hours.
As the PI, what should I expect?
You will be asked to pull records/lab notebooks that demonstrate the protocol was followed as approved. You will be asked questions about how the research project is going in relation to problems or adverse events. The scope of review varies greatly depending on the research, and may include:
- A tour of the animal room and surgery space.
- Viewing a procedure at a date and time agreed upon.
What are the possible outcomes?
There are several actions that could result from a PAM review. They include, but are not limited to:
- All procedures are compliant, no follow-up needed.
- Minor deficiencies, which will be listed in a letter to the PI from the compliance officer. The PI will then send a response back to the compliance officer with their plans and timeline to address the issues.
- Significant deficiencies, which will be listed in a letter to the PI from the compliance officer and reported to the IACUC immediately after PAM review. The PI will then send a response back to the compliance officer with their plans and timeline to address the issues. Furthermore, the investigator will be reviewed again within six months to ensure compliance.
When will I know of the outcomes?
The PAM review letter will be sent to the PI within 10 business days from the review date.
What if the PI is unable to attend the scheduled PAM meeting?
The preferred option would be to meet at a mutually agreeable time for both the PAM reviewers and the PI and their staff. If the PI is not able to attend, the PI may designate a representative for the PAM review.